(Q46207848)

20 December 2017

title

Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma (English)

1 reference

20 December 2017

Adaptive radiation therapy

main subject

0 references

Pei-Wei Shueng

9

0 references

author name string

Chen-Hsi Hsieh

1

1 reference

20 December 2017

Kuo-Shyang Jeng

2

1 reference

20 December 2017

Ching-Chung Lin

3

1 reference

20 December 2017

Chi-Kuan Chen

4

1 reference

20 December 2017

Chia-Yuan Liu

5

1 reference

20 December 2017

Chin-Ping Lin

6

1 reference

20 December 2017

Hung-Chi Tai

7

1 reference

20 December 2017

Chao-Hsing Wang

8

1 reference

20 December 2017

Yu-Jen Chen

10

1 reference

20 December 2017

publication date

1 January 2009

1 reference

20 December 2017

Clinical Drug Investigation

published in

1 reference

20 December 2017

volume

29

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

65-71

1 reference

20 December 2017

Radiation therapy and sorafenib: clinical data and rationale for the combination in metastatic renal cell carcinoma

cites work

1 reference

12 December 2020

Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway

1 reference

12 December 2020

Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors

1 reference

12 December 2020

Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.

1 reference

12 December 2020

Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study

1 reference

12 December 2020

Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Should hepatomas be treated with hepatic resection or transplantation?

1 reference

12 December 2020

Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy

1 reference

12 December 2020

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

1 reference

12 December 2020

Transection of the oesophagus for bleeding oesophageal varices

1 reference

12 December 2020

Cancer stem cells: are we missing the target?

1 reference

12 December 2020

Treatment of hepatocellular carcinoma: too many options?

1 reference

12 December 2020

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

1 reference

12 December 2020

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

12 December 2020

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

12 December 2020

Design of clinical trials of radiation combined with antiangiogenic therapy

1 reference

12 December 2020

Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable.

1 reference

12 December 2020

10.2165/0044011-200929010-00007

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017